Page last updated: 2024-09-03

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and oxazoles

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with oxazoles in 1 studies

Compound Research Comparison

Studies
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Trials
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Recent Studies (post-2010)
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Studies
(oxazoles)
Trials
(oxazoles)
Recent Studies (post-2010) (oxazoles)
36119,2813662,561

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liong, EC; Nanji, AA; Tipoe, GL; Xiao, J1

Other Studies

1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and oxazoles

ArticleYear
Thromboxane inhibitors attenuate inflammatory and fibrotic changes in rat liver despite continued ethanol administrations.
    Alcoholism, clinical and experimental research, 2013, Volume: 37, Issue:1

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System Depressants; Cyclooxygenase 2; Endotoxins; Ethanol; Fatty Liver, Alcoholic; Fibrosis; Lipid Peroxidation; Liver; Male; NF-kappa B; Oxazoles; Pyridines; Rats; Rats, Wistar; Receptors, Thromboxane; RNA, Messenger; Thromboxane-A Synthase; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2013